Elliott, BVMS, MRCVS is a veterinarian with over 30 years of experience in veterinary surgery and companion animal practice
And again, I have nothing to do with it
If FDA does not return tirzepatide and semaglutide to its shortage list, companies compounding and selling them will need to prepare for litigation and/or find alternative products
Sleep disturbance, cognitive decline, and dementia: a review
Some laxatives can interact with other medications
On April 1, 2026, the FDA issued a significant policy clarification targeting the most common remaining workaround: compounders and telehealth providers had been adding a secondary ingredient most commonly vitamin B12 to their semaglutide formulations and marketing them as distinct, patient-specific products not subject to the "essentially a copy" prohibition